Can raised guidance fuel Eli Lilly stock rally?

Traders Union
All News
Stocks
Eli Lilly jumps 3.01% to $1,220 today

Highlights

Eli Lilly raised full-year sales and profit targets as second quarter revenue surged 48% to $23 billion.
The company completed acquisitions and expanded manufacturing investment to enhance operational capacity and sustain growth momentum.
Eli Lilly stock maintains a strong bullish trend with most technical indicators overbought; price is forecast to trade between $1,165 and $1,274 over the next 2 to 3 days.

Upward guidance revision and acquisitions drive bullish sentiment

Eli Lilly has raised its full-year sales and profit targets after delivering a robust second quarter, with revenue surging 48% to $23.0 billion according to Finance Yahoo. This outperformance and upward revision in guidance signal improved business momentum and have spurred heightened investor demand for the stock. Alongside these results, the company completed several acquisitions and increased investment in manufacturing, moves designed to broaden operational scope and boost productive capacity, both of which further enhance its growth outlook.

Sustained bullish momentum as technical signals enter overbought territory

On the technical front, LLY is trading above the MA-20 at $1,191 and MA-50 at $1,158 on the hourly timeframe, and also remains well above its long-term MA-200 at $1,033. The Ichimoku Kijun currently stands at $1,189, acting as immediate support. Momentum readings are strong: both MACD and ADX signal Buy, while the RSI at 74.37 is in overbought territory. Both Stochastic RSI and CCI confirm overbought conditions, and Bull/Bear Power also shows that buyers are dominant. The Awesome Oscillator aligns with the prevailing positive trend. Price is near today’s high and volatility is moderate, with consistent bullish momentum displaying across intraday indicators. However, traders should note the multiple overbought oscillator readings.

Narrow trading band expected as probability favors further gains

In the short term, the expected trading range for LLY is $1,165 to $1,274 over the next two to three trading days. With a 72% probability of an upward move and only 28% likelihood of a downward shift, the baseline scenario expects the price to remain within this band as short-term positions rebalance. A break above resistance could accelerate further gains, while a failure of support might see LLY returning toward the lower end of the forecast range.

Anton Kharitonov, analyst at Traders Union, sees Eli Lilly’s recent rally as supported by fundamental strength and positive sentiment. He notes that technical momentum remains strong, but overbought indicators and high expectations warrant caution. The expert believes upside is intact for now, but warns of risk if support near $1,189 fails. "The base case is for consolidation above $1,189, but if supports give way, a pullback toward $1,165 is likely."

In a recent review, analysts noted that Eli Lilly shares had outperformed following strong quarterly results and upward guidance, helping drive broader equity gains despite a mixed market backdrop. The current analysis strengthens that view with evidence of sustained technical momentum, suggesting traders should monitor the $1,165 to $1,274 range as key levels for potential breakouts or retracements in the near term.

Source of Data: LLY Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.